Palliative bipolar electrocoagulation treatment of malignant gastroesophageal strictures

Massimo Conio, Luigina Bonelli, Hugo Martines, Francesco Munizzi, Hugo Aste

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Seventeen patients with non-resectable circumferential malignant strictures of the esophagus (n=13) or the gastroesophageal junction (n=4) were treated with a bipolar electrocoagulation tumor probe (BICAP). None had received prior radiotherapy or chemotherapy. The mean tumor length was 7.2 cm. After treatment swallowing was improved in 86.7% of the patients. The mean duration of response to the first treatment was 18 days. Three major complications (1 fatal hemorrhage, 2 tracheoesophageal fistulae) and two minor complications (chest pain) were observed. The overall actuarial survival rate after 13 months of follow-up was 20%. The BICAP tumor probe can be considered an efficacious and safe device in selected patients with long, circumferential esophageal cancers.

Original languageEnglish
Pages (from-to)164-167
Number of pages4
JournalSurgical Endoscopy and Other Interventional Techniques
Volume4
Issue number3
DOIs
Publication statusPublished - 1990

Fingerprint

Electrocoagulation
Pathologic Constriction
Tracheoesophageal Fistula
Esophagogastric Junction
Neoplasms
Esophageal Neoplasms
Deglutition
Chest Pain
Esophagus
Radiotherapy
Therapeutics
Survival Rate
Hemorrhage
Drug Therapy
Equipment and Supplies

Keywords

  • Bipolar electrocoagulation treatment
  • Malignant gastroesophageal strictures
  • Palliative therapy

ASJC Scopus subject areas

  • Surgery

Cite this

Palliative bipolar electrocoagulation treatment of malignant gastroesophageal strictures. / Conio, Massimo; Bonelli, Luigina; Martines, Hugo; Munizzi, Francesco; Aste, Hugo.

In: Surgical Endoscopy and Other Interventional Techniques, Vol. 4, No. 3, 1990, p. 164-167.

Research output: Contribution to journalArticle

Conio, Massimo ; Bonelli, Luigina ; Martines, Hugo ; Munizzi, Francesco ; Aste, Hugo. / Palliative bipolar electrocoagulation treatment of malignant gastroesophageal strictures. In: Surgical Endoscopy and Other Interventional Techniques. 1990 ; Vol. 4, No. 3. pp. 164-167.
@article{04702f541e3e4477ba18cc0efa63c165,
title = "Palliative bipolar electrocoagulation treatment of malignant gastroesophageal strictures",
abstract = "Seventeen patients with non-resectable circumferential malignant strictures of the esophagus (n=13) or the gastroesophageal junction (n=4) were treated with a bipolar electrocoagulation tumor probe (BICAP). None had received prior radiotherapy or chemotherapy. The mean tumor length was 7.2 cm. After treatment swallowing was improved in 86.7{\%} of the patients. The mean duration of response to the first treatment was 18 days. Three major complications (1 fatal hemorrhage, 2 tracheoesophageal fistulae) and two minor complications (chest pain) were observed. The overall actuarial survival rate after 13 months of follow-up was 20{\%}. The BICAP tumor probe can be considered an efficacious and safe device in selected patients with long, circumferential esophageal cancers.",
keywords = "Bipolar electrocoagulation treatment, Malignant gastroesophageal strictures, Palliative therapy",
author = "Massimo Conio and Luigina Bonelli and Hugo Martines and Francesco Munizzi and Hugo Aste",
year = "1990",
doi = "10.1007/BF02336597",
language = "English",
volume = "4",
pages = "164--167",
journal = "Surgical Endoscopy",
issn = "0930-2794",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Palliative bipolar electrocoagulation treatment of malignant gastroesophageal strictures

AU - Conio, Massimo

AU - Bonelli, Luigina

AU - Martines, Hugo

AU - Munizzi, Francesco

AU - Aste, Hugo

PY - 1990

Y1 - 1990

N2 - Seventeen patients with non-resectable circumferential malignant strictures of the esophagus (n=13) or the gastroesophageal junction (n=4) were treated with a bipolar electrocoagulation tumor probe (BICAP). None had received prior radiotherapy or chemotherapy. The mean tumor length was 7.2 cm. After treatment swallowing was improved in 86.7% of the patients. The mean duration of response to the first treatment was 18 days. Three major complications (1 fatal hemorrhage, 2 tracheoesophageal fistulae) and two minor complications (chest pain) were observed. The overall actuarial survival rate after 13 months of follow-up was 20%. The BICAP tumor probe can be considered an efficacious and safe device in selected patients with long, circumferential esophageal cancers.

AB - Seventeen patients with non-resectable circumferential malignant strictures of the esophagus (n=13) or the gastroesophageal junction (n=4) were treated with a bipolar electrocoagulation tumor probe (BICAP). None had received prior radiotherapy or chemotherapy. The mean tumor length was 7.2 cm. After treatment swallowing was improved in 86.7% of the patients. The mean duration of response to the first treatment was 18 days. Three major complications (1 fatal hemorrhage, 2 tracheoesophageal fistulae) and two minor complications (chest pain) were observed. The overall actuarial survival rate after 13 months of follow-up was 20%. The BICAP tumor probe can be considered an efficacious and safe device in selected patients with long, circumferential esophageal cancers.

KW - Bipolar electrocoagulation treatment

KW - Malignant gastroesophageal strictures

KW - Palliative therapy

UR - http://www.scopus.com/inward/record.url?scp=0025581323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025581323&partnerID=8YFLogxK

U2 - 10.1007/BF02336597

DO - 10.1007/BF02336597

M3 - Article

C2 - 1702560

AN - SCOPUS:0025581323

VL - 4

SP - 164

EP - 167

JO - Surgical Endoscopy

JF - Surgical Endoscopy

SN - 0930-2794

IS - 3

ER -